Anti-S39AB/ SLC39A11/ C17orf26 monoclonal antibody

Anti-S39AB/ SLC39A11/ C17orf26 antibody for FACS & in-vivo assay

Target products collectionGo to SLC39A11/SLC39A11 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1614-Ab-1/ GM-Tg-hg-MP1614-Ab-2Anti-Human SLC39A11 monoclonal antibodyHuman
GM-Tg-rg-MP1614-Ab-1/ GM-Tg-rg-MP1614-Ab-2Anti-Rat SLC39A11 monoclonal antibodyRat
GM-Tg-mg-MP1614-Ab-1/ GM-Tg-mg-MP1614-Ab-2Anti-Mouse SLC39A11 monoclonal antibodyMouse
GM-Tg-cynog-MP1614-Ab-1/ GM-Tg-cynog-MP1614-Ab-2Anti-Cynomolgus/ Rhesus macaque SLC39A11 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1614-Ab-1/ GM-Tg-felg-MP1614-Ab-2Anti-Feline SLC39A11 monoclonal antibodyFeline
GM-Tg-cang-MP1614-Ab-1/ GM-Tg-cang-MP1614-Ab-2Anti-Canine SLC39A11 monoclonal antibodyCanine
GM-Tg-bovg-MP1614-Ab-1/ GM-Tg-bovg-MP1614-Ab-2Anti-Bovine SLC39A11 monoclonal antibodyBovine
GM-Tg-equg-MP1614-Ab-1/ GM-Tg-equg-MP1614-Ab-2Anti-Equine SLC39A11 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1614-Ab-1/ GM-Tg-hg-MP1614-Ab-2; GM-Tg-rg-MP1614-Ab-1/ GM-Tg-rg-MP1614-Ab-2;
GM-Tg-mg-MP1614-Ab-1/ GM-Tg-mg-MP1614-Ab-2; GM-Tg-cynog-MP1614-Ab-1/ GM-Tg-cynog-MP1614-Ab-2;
GM-Tg-felg-MP1614-Ab-1/ GM-Tg-felg-MP1614-Ab-2; GM-Tg-cang-MP1614-Ab-1/ GM-Tg-cang-MP1614-Ab-2;
GM-Tg-bovg-MP1614-Ab-1/ GM-Tg-bovg-MP1614-Ab-2; GM-Tg-equg-MP1614-Ab-1/ GM-Tg-equg-MP1614-Ab-2
Products NameAnti-SLC39A11 monoclonal antibody
Formatmab
Target NameSLC39A11
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SLC39A11 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species S39AB/ SLC39A11/ C17orf26 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLPm001364mouse Slc39a11 Lentivirus plasmid
    ORF Viral VectorpGMLPm001365mouse Slc39a11 Lentivirus plasmid
    ORF Viral VectorvGMLPm001364mouse Slc39a11 Lentivirus particle
    ORF Viral VectorvGMLPm001365mouse Slc39a11 Lentivirus particle


    Target information

    Target IDGM-MP1614
    Target NameSLC39A11
    Gene ID201266,69806,287796,695406,106559224,101090564,615681,100052800
    Gene Symbol and Synonyms1810074D23Rik,C17orf26,SLC39A11,ZIP-11,ZIP11
    Uniprot AccessionQ8N1S5,Q6P6S2,Q2YDD4
    Uniprot Entry NameS39AB_HUMAN,S39AB_RAT,S39AB_BOVIN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000133195
    Target ClassificationN/A

    The target: SLC39A11, gene name: SLC39A11, also named as C17orf26, ZIP-11, ZIP11. Predicted to enable zinc ion transmembrane transporter activity. Predicted to be involved in zinc ion transmembrane transport. Predicted to be located in Golgi apparatus; nucleus; and plasma membrane. Predicted to be active in membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.